Login / Signup

Concurrent use of hormonal long-acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013-2021: a retrospective cohort study.

Luke E GrzeskowiakVivienne MooreKelly HallJenni IlomäkiDanielle SchoenakerElizabeth LovegroveDanielle MazzaKirsten I BlackDebra S KennedyMichael J DaviesAlice Rumbold
Published in: The Medical journal of Australia (2024)
Concurrent use of highly effective hormonal contraception at the time of first dispensing of category X medications is low in Australia, raising concerns about potential fetal harms during unintended pregnancies. Awareness of the importance of hormonal contraception and its uptake by women prescribed category X medications should be increased.
Keyphrases
  • polycystic ovary syndrome
  • insulin resistance
  • pregnancy outcomes
  • locally advanced
  • preterm birth
  • type diabetes
  • metabolic syndrome
  • cervical cancer screening
  • adipose tissue
  • squamous cell carcinoma
  • climate change